Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea
· Delayed Price · Currency is KRW 6,510.00
-170.00 (-2.54%)
Last updated: Apr 29, 2026, 2:04 PM KST
Bukwang Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 649,214 | 373,446 | 314,207 | 417,573 | 598,978 | 883,065 | Upgrade
|
| Market Cap Growth | 151.56% | 18.85% | -24.75% | -30.29% | -32.17% | -54.11% | Upgrade
|
| Enterprise Value | 513,678 | 236,540 | 280,401 | 368,683 | 519,044 | 826,852 | Upgrade
|
| Last Close Price | 6580.00 | 3785.00 | 4109.78 | 5461.80 | 7834.55 | 11550.36 | Upgrade
|
| PE Ratio | 43.29 | 29.74 | - | - | - | - | Upgrade
|
| Forward PE | - | 58.75 | 58.75 | 58.75 | 58.75 | 58.75 | Upgrade
|
| PS Ratio | 3.23 | 1.86 | 1.96 | 3.32 | 3.14 | 4.84 | Upgrade
|
| PB Ratio | 1.90 | 1.10 | 1.29 | 1.78 | 2.20 | 3.15 | Upgrade
|
| P/TBV Ratio | 1.93 | 1.11 | 1.32 | 1.93 | 2.34 | 3.36 | Upgrade
|
| P/FCF Ratio | 45.70 | 26.29 | 9.69 | - | 49.25 | 34.31 | Upgrade
|
| P/OCF Ratio | 30.25 | 17.40 | 9.14 | - | 36.39 | 33.29 | Upgrade
|
| EV/Sales Ratio | 2.56 | 1.18 | 1.75 | 2.93 | 2.72 | 4.53 | Upgrade
|
| EV/EBITDA Ratio | 26.11 | 12.04 | 48.99 | - | 106.23 | 79.01 | Upgrade
|
| EV/EBIT Ratio | 36.22 | 16.70 | 173.34 | - | - | 147.08 | Upgrade
|
| EV/FCF Ratio | 36.16 | 16.65 | 8.65 | - | 42.67 | 32.12 | Upgrade
|
| Debt / Equity Ratio | 0.24 | 0.24 | 0.33 | 0.34 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 4.09 | 4.09 | 13.88 | - | 0.19 | 0.15 | Upgrade
|
| Debt / FCF Ratio | 5.66 | 5.66 | 2.45 | - | 0.08 | 0.06 | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.40 | -0.21 | -0.31 | -0.31 | -0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.91 | -6.91 | -8.85 | 2.16 | -17.31 | -7.90 | Upgrade
|
| Net Debt / FCF Ratio | -9.56 | -9.56 | -1.56 | 5.89 | -6.95 | -3.21 | Upgrade
|
| Asset Turnover | 0.47 | 0.47 | 0.40 | 0.30 | 0.48 | 0.46 | Upgrade
|
| Inventory Turnover | 2.33 | 2.33 | 1.75 | 1.66 | 2.87 | 2.36 | Upgrade
|
| Quick Ratio | 2.09 | 2.09 | 4.37 | 1.93 | 3.90 | 4.79 | Upgrade
|
| Current Ratio | 2.57 | 2.57 | 5.76 | 2.61 | 4.90 | 5.95 | Upgrade
|
| Return on Equity (ROE) | 4.25% | 4.25% | -1.45% | -13.60% | -1.54% | -1.01% | Upgrade
|
| Return on Assets (ROA) | 2.08% | 2.08% | 0.25% | -5.65% | -0.04% | 0.88% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.93% | 7.11% | 0.91% | -21.45% | -0.12% | -2.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.00% | 4.00% | 0.50% | -11.30% | -0.10% | 1.60% | Upgrade
|
| Earnings Yield | 1.93% | 3.36% | -0.84% | -7.50% | -0.41% | -0.10% | Upgrade
|
| FCF Yield | 2.19% | 3.80% | 10.32% | -2.92% | 2.03% | 2.92% | Upgrade
|
| Payout Ratio | 39.28% | 39.28% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -21.98% | -21.98% | 1.06% | - | 0.01% | 0.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.